|
With this runup on high volume, a definite breakout from the past, you have to consider buyout on your list of possibilities. Alcon Surgical (aka Nestle Chocolate), one of the deeper corporate pockets worldwide, used to have a marketing relationship with VISX which was terminated when a major shareholder was able to demonstrate that Alcon probably harmed VISX in Europe rather than helping it, some years ago. Alcon, the jilted partner, may be making a second pass at VISX, this time, a genuine union rather than an engagement. What do you think, out there? Earnings are going to be better, but they just don't explain this frenzied runup. Yes, the momentum people may be hopping on, but there had to have been a stimulus to get this thing started so abruptly. |
